Results 281 to 290 of about 143,588 (347)

Case Report: A case of a pregnancy-associated breast cancer patient with a pathogenic variant in <i>BRCA1</i> who underwent staged risk-reducing salpingo-oophorectomy and contralateral risk-reducing mastectomy. [PDF]

Front Oncol
Takuwa H, Sasaki S, Goda N, Takeuchi M.
europepmc   +1 more source

Enhanced Detection of BRCA Copy Number Alterations Within a Commercial HRD Assay: Implications for Precision Oncology in Ovarian Cancer. [PDF]

Int J Mol Sci
De Bonis M, Iapicca P, De Paolis E, Brisighelli F, Evangelista J, Perrucci A, Ricciardi Tenore C, Maneri G, Concolino P, Piermattei A, Mozzetta I, Pasciuto T, Preziosi A, Giacò L, Duranti S, Nero C, Fagotti A, Minucci A.   +17 more
europepmc   +1 more source

Factors influencing uptake of risk-reducing mastectomy among unaffected Israeli BRCA1/BRCA2 pathogenic variant carriers. [PDF]

Fam Cancer
Laitman Y, Aharon K, Schloss T, Margolin L, Friedman E.   +4 more
europepmc   +1 more source

<i>SYTL4</i> May Serve as a New Predictive Biomarker for Survival and Trastuzumab Treatment Responsiveness in HER2-Positive Breast Cancer. [PDF]

Int J Mol Sci
Kordowitzki P.
europepmc   +1 more source

<i>BRCA1</i> Promoter CpG Methylation in Breast Cancer: A Pilot Study in African Women. [PDF]

Genes (Basel)
Willmer T, Makhetha M, Shaik AR, Mabasa L, Buccimazza I, Aldous C.   +5 more
europepmc   +1 more source

Correction: A comprehensive and accessible model for co-segregation analysis in BRCA1, BRCA2, and PALB2 variant classification. [PDF]

Hum Genet
Moghadasi S, Monajemi R, Braspenning ME, Vreeswijk MPG, Rodríguez-Girondo M.   +4 more
europepmc   +1 more source

Evolutionary constraint helps unmask a splicing regulatory region in BRCA1 exon 11

, 2012
Baralle, D., Douglas, A.G.L., Raponi, M., Wilson, D.I., Tammaro, C.   +4 more
core  

BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B). [PDF]

Breast Cancer
Sakai H, Kusumoto-Matsuo R, Hosonaga M, Nozawa K, Futamura M, Tanabe Y, Mukohara T, Shiraishi K, Toyama T, Yasojima H, Watanabe N, Sakai H, Iwasa T, Takeuchi N, Tada H, Sakai K, Chiba N, Takano T, Tsurutani J.   +18 more
europepmc   +1 more source

Ferroptosis and chemotherapy resistance in ovarian cancer: molecular mechanisms and therapeutic opportunities. [PDF]

J Ovarian Res
Li S, Yang L, Zhu Z.
europepmc   +1 more source